Low-dose oral anticoagulation and antiplatelet therapy with St. Jude medical heart valve prosthesis

Journal of Heart Valve Disease

Volumn 8, Issue 6, 1999, Pages 665-673

  Yamak, Birol ^a   Iscan, Zafer ^a   Mavitas, Binali ^a   Ulus, A Tulga ^a   Katircioglu, S Fehmi ^a   Tasdemir, Oguz ^a   Bayazit, Kemal ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b GÜVEN HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CHILD; DRUG EFFECT; FEMALE; HEART OUTPUT; HEART VALVE PROSTHESIS; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE; ASPIRIN; CHILD; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; WARFARIN;

EID: 0032700892     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Starr A, Edwards ML. Mitral replacement: Clinical experience with a ball-valve prosthesis. Ann Surg 1961;154:726-740
2. Antunes MJ. Clinical performance of St. Jude and Medtronic Hall prosthesis. A randomised comparative study. Ann Thorac Surg 1990;50:743-747
3. Czer LSC, Chaux A., Matloff JM, et al. Ten year experience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg 1990;100:167-174
4. Jaffe WM, Covardale HA, Roche AHG, Whitlock RML, Neutce JM, Barrat-Boyes BG. Rest and exercise hemodynamics of 20 to 23 mm allograft, Medtronic Intact (porcine), and St. Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg 1990;100:44-55
5. Kinsley RH, Antunes MJ, Colsen PR. St. Jude Medical valve replacement. An evaluation of valve performance. J Thorac Cardiovasc Surg 1986;92:343-360
6. Mattila SP, Mattila EJ, Harjula AL, Mattila KT, Luosta LV. Long-term follow-up of St. Jude Medical valve. Scan J Thorac Cardiovasc Surg 1990;24:121-123
7. Yamak B, Karagoz HY, Zorlutuna Y, Eralp A., Tasdemir O, Bayazit K. Low dose anticoagulant management of patients with St. Jude Medical mechanical valve prosthesis. Thorac Cardiovasc Surg 1993;41:38-42
8. Baudet EM, Oca CC, Rouges XF, et al. A 5.5 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985;90:137-144
9. Czer LSC, Matloff JM, Chaux A, De Robertis M, Yoganathan A, Gray RJ. A 6 year experience with the St. Jude Medical valve: Hemodynamic performance, surgical results, biocompatibility and follow-up. J Am Coll Cardiol 1985;6:904-912
10. Duncan JM, Cooley DA, Reul GJ, et al. Durability and low thrombogenicity of the St. Jude Medical valve at 5 year follow-up. Ann Thorac Surg 1986;42:500-505
11. Kopf GS, Hammond GL, Geha AS, Eleftereides J, Hashim SW. Long-term performance of the St. Jude Medical valve: Low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Circulation 1987;76(Suppl.III):III-132-III-136
12. Fernandez J, Laub GW, Akins MS, et al. Early and late phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients. J Thorac Cardiovasc Surg 1994;107:394-407
13. Armenti F, Stephenson LW, Edmunds LH. Simultaneous implantation St. Jude Medical aortic and mitral prosthesis. J Thorac Cardiovasc Surg 1987;94: 733-739
14. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1996;112:708-711
15. Arom KV, Nicoloff DM, Kersten TE, Northrup WF, III, Lindsay WG, Emery RW. Ten years' experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1989;47:831-837
16. Nakano K, Koyanagi H, Hashimoto A, et al. Twelve years' experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1994;57:697-703
17. Debetaz LF, Ruchat P, Hurni M, et al. St. Jude Medical valve prosthesis: An analysis of long-term outcome and prognostic factors. J Thorac Cardiovasc Surg 1997;133:134-148
18. Gohlke-Barwolf,C, Acar J, Oakley C, et al. Study group of the working group on valvular heart disease of the European Society of Cardiology: Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-1330
19. Nair CK, Mohiuddin SM, Hilleman DE, et al. Ten year results with the St. Jude Medical prosthesis. Am J Cardiol 1990;65:217-225
20. Burckhardt D, Striebel D, Vogt S, et al. Heart valve replacement with St. Jude Medical valve prosthesis: Long-term experience in 743 patients in Switzerland. Circulation 1988;78(Suppl.I):I-18-I-24
21. Akins CW. Mechanical cardiac valvular prosthesis. Ann Thorac Surg 1991;52:161-172
22. Sener E, Yamak B, Katircioglu SF, et al. Risk factors of reoperation for prosthetic heart valve dysfunction in the ten years 1984-1993. Thorac Cardiovasc Surg 1995;43:148-152
23. Kratz JM, Crawford FA, Jr., Sade RM, Crumbley AJ, Stroud MR. St. Jude prosthesis for aortic and mitral valve replacement: A ten year experience. Ann Thorac Surg 1993;56:462-468